We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
-3.51%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764%
AUM
$742M
AUM Growth
-$23M
Cap. Flow
+$42.3M
Cap. Flow %
5.7%
Top 10 Hldgs %
10.19%
Holding
640
New
74
Increased
161
Reduced
241
Closed
77

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.63M
2
MELI icon
Mercado Libre
MELI
+$3.11M
3
NVDA icon
NVIDIA
NVDA
+$2.9M
4
NFLX icon
Netflix
NFLX
+$2.8M
5
TRIP icon
TripAdvisor
TRIP
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Healthcare 18.55%
3 Industrials 16.95%
4 Financials 12.18%
5 Consumer Discretionary 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWO icon
501
iShares Russell 2000 Growth ETF
IWO
$14.1B
$260K 0.04%
+1,018
New +$287K
ASPN icon
502
Aspen Aerogels
ASPN
$403M
$257K 0.03%
40,278
-492
-1% -$4.74K
PL icon
503
Planet Labs
PL
$5.79B
$249K 0.03%
+73,787
New +$346K
WEX icon
504
WEX
WEX
$6.84B
$246K 0.03%
1,567
-146
-9% -$24K
MLTX icon
505
MoonLake Immunotherapeutics
MLTX
$1.04B
$240K 0.03%
+6,142
New +$265K
QNST icon
506
QuinStreet
QNST
$1.04B
$235K 0.03%
13,150
-6,635
-34% -$139K
SMMT icon
507
Summit Therapeutics
SMMT
$14.2B
$233K 0.03%
+12,070
New +$242K
TPB icon
508
Turning Point Brands
TPB
$1.43B
$231K 0.03%
3,884
-736
-16% -$45.6K
TCBX icon
509
Third Coast Bancshares
TCBX
$750M
$228K 0.03%
6,825
NATH icon
510
Nathan's Famous
NATH
$403M
$216K 0.03%
+2,238
New +$200K
RDWR icon
511
Radware
RDWR
$1.23B
$211K 0.03%
9,752
-617
-6% -$13.8K
S icon
512
SentinelOne
S
$7.8B
$208K 0.03%
11,459
-2,223
-16% -$48.2K
EYPT icon
513
EyePoint Inc
EYPT
$347M
$201K 0.03%
37,091
-451
-1% -$3.16K
III icon
514
Information Services Group
III
$259M
$198K 0.03%
50,595
+22,521
+80% +$73.9K
CRD.A icon
515
Crawford & Co Class A
CRD.A
$593M
$185K 0.02%
16,215
FOLD
516
DELISTED
Amicus Therapeutics
FOLD
$176K 0.02%
21,556
-63,583
-75% -$588K
PTEN icon
517
Patterson-UTI
PTEN
$4.86B
$175K 0.02%
+21,265
New +$178K
RLGT icon
518
Radiant Logistics
RLGT
$439M
$174K 0.02%
28,258
-11,464
-29% -$77.6K
ACEL icon
519
Accel Entertainment
ACEL
$943M
$167K 0.02%
16,842
AHCO icon
520
AdaptHealth
AHCO
$771M
$167K 0.02%
+15,363
New +$155K
BCRX icon
521
BioCryst Pharmaceuticals
BCRX
$2.08B
$166K 0.02%
22,122
-1,471
-6% -$11.9K
IMXI icon
522
International Money Express
IMXI
$424M
$161K 0.02%
+12,797
New +$219K
WNEB icon
523
Western New England Bancorp
WNEB
$277M
$157K 0.02%
16,884
-4,557
-21% -$42K
DOLE icon
524
Dole
DOLE
$1.25B
$153K 0.02%
10,562
-1,299
-11% -$17.9K
EGAN icon
525
eGain
EGAN
$136M
$143K 0.02%
29,573

Similar funds

Legato Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Legato Capital Management held 640 positions worth $742M, down 3% from $765M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Legato Capital Management deployed $42.3M of net new capital in Q1 2025, opening 74 new positions and adding to 161 existing holdings. Its largest new stake was TripAdvisor: 172,890 shares worth $2.45M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Kornit Digital, an estimated $3.3M trimmed.

  • Legato Capital Management's largest Q1 2025 buy was TripAdvisor: 172,890 shares worth $2.45M.
  • Legato Capital Management added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $3.63M increase.
  • Legato Capital Management's biggest Q1 2025 reduction was Kornit Digital, cutting an estimated $3.3M.
  • Legato Capital Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $4.19M.
  • Legato Capital Management's ten largest holdings make up 10% of its $742M portfolio in Q1 2025.
  • Legato Capital Management opened 74 new positions and closed 77 in Q1 2025.
  • Legato Capital Management's portfolio value fell 3% quarter-over-quarter to $742M.

Based on Legato Capital Management's 13F filing for Q1 2025, filed 6 May 2025.